This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

I. MEASUREMENT OF THE SPEED AND DURATION OF THE EFFECT FOLLOWING ORAL AND INTRAMUSCULAR ADMINISTRATION

ELLIOT L. SAGALL, M.D.; CHARLES D. HORN, M.D.; JOSEPH E. F. RISEMAN, M.D.

Arch Intern Med. 1943;71(4):460-473.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The value of quinidine in the treatment of certain acute cardiac arrhythmias is well recognized. There are numerous references in the literature about the use of quinidine in treating chronic auricular fibrillation. In this condition, however, conversion to normal sinus rhythm is not urgent, and the dose of quinidine may be gradually increased over a period of days, if necessary, until the desired effect is obtained. In the acute or paroxysmal arrhythmias (auricular tachycardia, auricular fibrillation, ventricular tachycardia, etc.) the abnormal rate and rhythm may cause cardiac pain, intense palpitation, dyspnea, faintness, vomiting, pulmonary edema, collapse and even death. Prompt treatment may be essential. Proper management of such conditions requires accurate knowledge of the speed and duration of action of the therapeutic agents employed. Little exact information is available, however, concerning the factors which determine the optimum methods for employing quinidine under such conditions.

The purpose of this communication is . . . [Full Text PDF of this Article]

Author Affiliations
BOSTON

From the Medical Research Laboratories of the Beth Israel Hospital and the Department of Medicine. Harvard Medical School.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?